NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Hemispherx BioPharma, Inc. (AMEX: HEB)
HEB Technical Analysis
5
As on 31st Oct 2017 HEB Share Price closed @ 0.31 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.52 & Strong Sell for SHORT-TERM with Stoploss of 0.34 we also expect STOCK to react on Following IMPORTANT LEVELS. |
HEB Share Price
Open | 0.31 | Change | Price | % |
High | 0.31 | 1 Day | 0.01 | 3.33 |
Low | 0.30 | 1 Week | 0.00 | 0.00 |
Close | 0.31 | 1 Month | -0.02 | -6.06 |
Volume | 219715 | 1 Year | -0.60 | -65.93 |
52 Week High 0.94 | 52 Week Low 0.30 |
AMEX USA Most Active Stocks
PAL | 0.05 | -50.00% |
NGD | 3.29 | -6.80% |
RBY | 0.03 | -70.00% |
LODE | 0.12 | -7.69% |
PBTH | 8.23 | 0.37% |
GGR | 0.02 | 100.00% |
VTG | 0.05 | -16.67% |
SYRG | 8.13 | 0.87% |
GSX | 0.02 | 0.00% |
SHZ | 0.10 | -16.67% |
AMEX USA Top Gainers Stocks
AMEX USA Top Losers Stocks
HEB Daily Charts |
HEB Intraday Charts |
Whats New @ Bazaartrend |
HEB Free Analysis |
|
HEB Important Levels Intraday
SUPPORT | 0.00 |
SUPPORT | 0.00 |
RESISTANCE | 0.32 |
RESISTANCE | 0.32 |
SUPPORT | 0.30 |
SUPPORT | 0.30 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
HEB Target for Month January
4th UP TARGET | 0.44 |
3rd UP TARGET | 0.4 |
2nd UP TARGET | 0.37 |
1st UP TARGET | 0.35 |
1st DOWN TARGET | 0.27 |
2nd DOWN TARGET | 0.25 |
3rd DOWN TARGET | 0.22 |
4th DOWN TARGET | 0.18 |
HEB Weekly Target
4th UP TARGET | 0.00 |
3rd UP TARGET | 0.00 |
2nd UP TARGET | 0.00 |
1st UP TARGET | 0.00 |
1st DOWN TARGET | 0.00 |
2nd DOWN TARGET | 0.00 |
3rd DOWN TARGET | 0.00 |
4th DOWN TARGET | 0.00 |
HEB Target for Year 2021
4th UP TARGET | 0 |
3rd UP TARGET | 0 |
2nd UP TARGET | 0 |
1st UP TARGET | 0 |
1st DOWN TARGET | 0 |
2nd DOWN TARGET | 0 |
3rd DOWN TARGET | 0 |
4th DOWN TARGET | 0 |
Hemispherx BioPharma, Inc. ( AMEX USA Symbol : HEB )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
HEB Other Details
Segment | EQ | |
Market Capital | 115221192.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
HEB Address
![]() |
One Penn Center 1617 JFK Boulevard Philadelphia, PA 19103 United States Phone: 215-988-0080 Fax: 215-988-1739 |
HEB Latest News
HEB Business Profile
Hemispherx Biopharma, Inc., a specialty pharmaceutical company, is engaged in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the United States. The company products comprise Ampligen, an experimental drug, which is under clinical development for the treatment of chronic fatigue syndrome, Hepatitis B, HIV, renal cell carcinoma, and malignant melanoma. Its products also include Alferon N Injection, an injectable formulation of natural alpha interferon for the treatment of certain categories of genital warts; and Alferon LDO, a low-dose oral liquid formulation of natural alpha interferon for the treatment of influenza, seasonal influenza, and other emerging viruses. The company was founded in 1990 and is headquartered in Philadelphia, Pennsylvania.
© 2005-2019 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service